- Home
- PHIO vs BFRI Comparison
PHIO vs BFRI Comparison
Compare PHIO & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHIO
- BFRI
- Stock Information
- Founded
- PHIO 2011
- BFRI 1997
- Country
- PHIO United States
- BFRI United States
- Employees
- PHIO N/A
- BFRI N/A
- Industry
- PHIO Biotechnology: Pharmaceutical Preparations
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- PHIO Health Care
- BFRI Health Care
- Exchange
- PHIO Nasdaq
- BFRI Nasdaq
- Market Cap
- PHIO 8.6M
- BFRI 7.5M
- IPO Year
- PHIO N/A
- BFRI 2021
- Fundamental
- Price
- PHIO $2.00
- BFRI $0.56
- Analyst Decision
- PHIO Strong Buy
- BFRI Strong Buy
- Analyst Count
- PHIO 1
- BFRI 1
- Target Price
- PHIO $4.00
- BFRI $2.75
- AVG Volume (30 Days)
- PHIO 875.3K
- BFRI 174.4K
- Earning Date
- PHIO 05-15-2025
- BFRI 05-15-2025
- Dividend Yield
- PHIO N/A
- BFRI N/A
- EPS Growth
- PHIO N/A
- BFRI N/A
- EPS
- PHIO N/A
- BFRI N/A
- Revenue
- PHIO N/A
- BFRI $37,997,000.00
- Revenue This Year
- PHIO N/A
- BFRI $18.57
- Revenue Next Year
- PHIO N/A
- BFRI $20.17
- P/E Ratio
- PHIO N/A
- BFRI N/A
- Revenue Growth
- PHIO N/A
- BFRI 14.28
- 52 Week Low
- PHIO $0.97
- BFRI $0.56
- 52 Week High
- PHIO $9.79
- BFRI $2.22
- Technical
- Relative Strength Index (RSI)
- PHIO 54.98
- BFRI 29.93
- Support Level
- PHIO $1.71
- BFRI $0.58
- Resistance Level
- PHIO $2.08
- BFRI $0.68
- Average True Range (ATR)
- PHIO 0.13
- BFRI 0.06
- MACD
- PHIO 0.01
- BFRI -0.01
- Stochastic Oscillator
- PHIO 76.32
- BFRI 11.21
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.